|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1634 I St. NW |
Address2 | Suite 1200 |
City | Washington |
State | DC |
Zip Code | 20006 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 401103938-63
|
||||||||
|
6. House ID# 431750014
|
TYPE OF REPORT | 8. Year | 2017 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Jeffery Mortier |
Date | 4/20/2017 5:49:41 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Affordable Care Act Issues: Small group expansion; Risk Corridors; Delivery system reform; Consumer experience; Back end issues; Implementation issues; Regulations; Premiums; Exchanges; Supreme Court decision implications
Other Major Health Care Related Issues: Cybersecurity; Medicare Advantage; Reinsurance; Health care quality issues; Community health management; Siteneutral
Payments; Dialysis care funding mechanism; Patient reform; Payment reform; Opioid abuse; Medical
Loss Ratios; Mental health parity implementation
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs
to be included in the coverage options offered by OPM; Alternative structures for the FEHBM.
S 123 Introduced January 8, 2015 by Marco Rubio (RFL)
Obamacare Taxpayer Bailout Prevention Act Repeals the provision of the
Patient Protection and Affordable Care Act that directs the Secretary of Health and Human Services to establish and administer a
program of risk corridors for calendar years 2014, 2015, and 2016 under which a qualified.
S. 1099 Introduced April 27, 2015 by Tim Scott (RSC)
A bill to amend the Patient Protection and Affordable Care Act to provide
States with flexibility in determining the size of employers in the small group market
HR 221 Introduced January 8, 2015 by Andy Harris (RMD)
Taxpayer bailout of health insurers
HR 928 Introduced February 12, 2015 by Charles Boustany (RLA)
This bill repeals a provision of the Patient Protection and
Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 1624 Introduced March 25, 2015 by Brett Guthrie (RKY)
To amend title I of the Patient Protection and Affordable Care Act and
title XXVII of the Public Health Service Act to revise the definition of small employer.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Labor - Dept of (DOL), White House Office, Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jeff |
MacKinnon |
|
LD & LA Rep. Joe Barton (RTexas) |
|
Joseph |
Vasapoli |
|
Min. Counsel, Energy&Comm, Special Asst. DOE |
|
Jeffery |
Mortier |
|
Prof Staff on E&C Cmte and LA Rep Whitfield |
|
Jody |
Gale |
|
|
|
Sarah |
Walter |
|
Former Legislative Director/Chief Counsel, Sen. John Breaux |
|
J. Daniel |
Walsh |
|
LD Rep. Wayne Gilchrest and LA Rep. Jack Buechner |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
ACA Risk Corridors, Federal Health Employee Benefit Program (FEHBP) offerings; Government contribution to FEHBP premiums;
Reinsurance; Regional PPO Language; H.R. 1624 Protecting Affordable Coverage of Employees Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jeff |
MacKinnon |
|
LD & LA Rep. Joe Barton (RTexas) |
|
Joseph |
Vasapoli |
|
Min. Counsel, Energy&Comm, Special Asst. DOE |
|
Jeffery |
Mortier |
|
Prof Staff on E&C Cmte and LA Rep Whitfield |
|
Jody |
Gale |
|
|
|
Sarah |
Walter |
|
Former Legislative Director/Chief Counsel, Sen. John Breaux |
|
J. Daniel |
Walsh |
|
LD Rep. Wayne Gilchrest and LA Rep. Jack Buechner |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Laboratory developed tests
21st Century Cures
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (RMI)
This bill amends the Public Health Service Act to
reauthorize the National Institutes of Health (NIH) through FY2018. The NIH Innovation Fund is established to fund a strategic plan,
early stage investigators, and highrisk,
highreward
research. The NIH may require scientific data to be shared if the research is fully
funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on
clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for
21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive
measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to
these drugs
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jeff |
MacKinnon |
|
LD & LA Rep. Joe Barton (RTexas) |
|
Joseph |
Vasapoli |
|
Min. Counsel, Energy&Comm, Special Asst. DOE |
|
Jeffery |
Mortier |
|
Prof Staff on E&C Cmte and LA Rep Whitfield |
|
Jody |
Gale |
|
|
|
Sarah |
Walter |
|
Former Legislative Director/Chief Counsel, Sen. John Breaux |
|
J. Daniel |
Walsh |
|
LD Rep. Wayne Gilchrest and LA Rep. Jack Buechner |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Medicare/Medicaid Issues: Chronic care improvement ideas; Medicare A & B; Delivery System Reforms; Benefit Restructuring ;
Medigap; Medicare Advantage Risk Delay; Community Health Management; Medicare fraud; Cybersecurity; ICD10;
Medicare
Prescription Drug Integrity; Provider directories
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (RMI)
This bill amends the Public Health Service Act to
reauthorize the National Institutes of Health (NIH) through FY2018. The NIH Innovation Fund is established to fund a strategic plan,
early stage investigators, and highrisk,
highreward
research. The NIH may require scientific data to be shared if the research is fully
funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on
clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for
21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive
measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to
these drugs.
HR 928 Introduced February 12, 2015 by Charles Boustany (RLA)
To repeal the annual fee on health insurance providers enacted by
the Patient Protection and Affordable Care Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jeff |
MacKinnon |
|
LD & LA Rep. Joe Barton (RTexas) |
|
Joseph |
Vasapoli |
|
Min. Counsel, Energy&Comm, Special Asst. DOE |
|
Jeffery |
Mortier |
|
Prof Staff on E&C Cmte and LA Rep Whitfield |
|
Jody |
Gale |
|
|
|
Sarah |
Walter |
|
Former Legislative Director/Chief Counsel, Sen. John Breaux |
|
J. Daniel |
Walsh |
|
LD Rep. Wayne Gilchrest and LA Rep. Jack Buechner |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Health Insurance Tax; IRC section 833(b) tax provisions; Medical Loss Ratio definition to qualify for 833(b) tax deduction; Tax ID
number reporting; Cadillac tax; Tax extenders; Device tax repeal; Tax reform
HR 928 Introduced February 12, 2015 by Charles Boustany (RLA)
To repeal the annual fee on health insurance providers enacted by
the Patient Protection and Affordable Care Act.
S 183 Introduced January 16, 2015 by John Barrasso (RWY)
Jobs and Premium Protection Act This bill repeals a provision of the
Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Treasury - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jeff |
MacKinnon |
|
LD & LA Rep. Joe Barton (RTexas) |
|
Jeff |
Mortier |
|
Prof Staff on E&C Cmte and LA Rep Whitfield |
|
Joseph |
Vasapoli |
|
Min. Counsel, Energy&Comm, Special Asst. DOE |
|
Jody |
Gale |
|
|
|
Sarah |
Walter |
|
Former Legislative Director/Chief Counsel, Sen. John Breaux |
|
J. Daniel |
Walsh |
|
LD Rep. Wayne Gilchrest and LA Rep. Jack Buechner |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |